Boston Trust Walden Corp has opened a new $67.9M position in $GMED, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 09-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $GMED.
$GMED Hedge Fund Activity
We have seen 259 institutional investors add shares of $GMED stock to their portfolio, and 243 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MADISON AVENUE PARTNERS, LP added 1,712,148 shares (+inf%) to their portfolio in Q2 2025, for an estimated $101,050,974
- JANUS HENDERSON GROUP PLC added 1,200,676 shares (+17.1%) to their portfolio in Q2 2025, for an estimated $70,863,897
- BOSTON TRUST WALDEN CORP added 1,185,461 shares (+inf%) to their portfolio in Q3 2025, for an estimated $67,891,351
- RTW INVESTMENTS, LP removed 1,125,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $66,397,500
- INVESCO LTD. removed 1,099,608 shares (-54.4%) from their portfolio in Q2 2025, for an estimated $64,898,864
- FULLER & THALER ASSET MANAGEMENT, INC. removed 919,115 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $54,246,167
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 873,784 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $51,570,731
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$GMED Insider Trading Activity
$GMED insiders have traded $GMED stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $GMED stock by insiders over the last 6 months:
- ANN D RHOADS sold 10,000 shares for an estimated $584,600
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$GMED Government Contracts
We have seen $1,678,925 of award payments to $GMED over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PROS SPINE IMPLANTS POST SURG: $73,899
- 4567273135!SABLE: $44,259
- PROS POST SURGERY: $43,116
- 4568294217!CREO STABILIZATION SYSTEM: $36,585
- PROS-POSTSURG SPINE: $34,652
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$GMED Congressional Stock Trading
Members of Congress have traded $GMED stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $GMED stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 06/17 and 2 sales worth up to $30,000 on 07/10, 06/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$GMED Analyst Ratings
Wall Street analysts have issued reports on $GMED in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 08/08/2025
- Morgan Stanley issued a "Overweight" rating on 07/15/2025
- Piper Sandler issued a "Overweight" rating on 05/09/2025
To track analyst ratings and price targets for $GMED, check out Quiver Quantitative's $GMED forecast page.
$GMED Price Targets
Multiple analysts have issued price targets for $GMED recently. We have seen 5 analysts offer price targets for $GMED in the last 6 months, with a median target of $68.0.
Here are some recent targets:
- Vik Chopra from Wells Fargo set a target price of $66.0 on 08/08/2025
- William Plovanic from Canaccord Genuity set a target price of $90.0 on 07/22/2025
- Drew Ranieri from Morgan Stanley set a target price of $68.0 on 07/15/2025
- Richard Newitter from Truist Securities set a target price of $68.0 on 05/12/2025
- Matt O'Brien from Piper Sandler set a target price of $80.0 on 05/09/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $GMED ticker page for more data.
